Related Experiment Video
Updated: Jun 21, 2026
08:53
Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model
Published on: January 1, 2017
Zoledronic acid decreases bone formation without causing osteocyte death in mice
S S Huja1, S A Fernandez, Christina Phillips
1Division of Orthodontics, College of Dentistry, The Ohio State University, 305 W. 12th St., Columbus, OH 43210, USA. huja.1@osu.edu
Archives of Oral Biology
|July 14, 2009
Summary
Zoledronic acid (ZA) did not harm mouse osteocytes but significantly reduced bone formation. This bisphosphonate
Area of Science:
- Bone Biology
- Pharmacology
- Osteonecrosis Research
Background:
- Bisphosphonates are linked to osteonecrosis of the jaw.
- Zoledronic acid (ZA) is a potent bisphosphonate.
- Understanding ZA's direct effects on bone cells is crucial.
Purpose of the Study:
- To investigate the impact of zoledronic acid (ZA) on osteocyte viability.
- To assess the effect of ZA on bone formation rates.
- To determine if ZA directly causes osteocyte death.
Main Methods:
- C57BL/6 mice received weekly zoledronic acid (ZA) injections for 9 weeks.
- Osteocyte viability assessed via lactate dehydrogenase (LDH) assay.
- Bone formation evaluated using histomorphometry and calcein labeling.
Main Results:
- No evidence of osteocyte necrosis was found in ZA-treated mice.
- Zoledronic acid (ZA) was not directly cytotoxic to mouse osteocytes.
- Significant suppression of bone formation indices observed in ZA group.
Conclusions:
- Zoledronic acid (ZA) does not induce osteocyte death.
- ZA severely suppresses bone formation, potentially impacting bone healing.
- Further research needed on clinical implications of ZA-induced bone formation reduction.
Related Concept Videos
01:31Osteoclasts in Bone Remodeling
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
01:29Bone Disorders
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...